Top Markets
Coin of the day
Jenscare Scientific Co., Ltd. Jenscare Scientific Co., Ltd.

Jenscare Scientific Co., Ltd.

9877
Classifica tra le azioni #15054
Jenscare Scientific Co., Ltd. operates as a medical technology enterprise... Jenscare Scientific Co., Ltd. operates as a medical technology enterprise dedicated to advancing interventional therapies for structural heart conditions within the People's Republic of China. Among its pipeline, the company features LuX-Valve, an investigational transcatheter tricuspid valve replacement (TTVR) system designed for patients suffering from severe tricuspid regurgitation who face elevated surgical risks. Additionally, Ken-Valve represents another key product candidate, a transcatheter aortic valve replacement (TAVR) aimed at addressing severe aortic regurgitation, often co-occurring with aortic stenosis. The applications of Jenscare's portfolio extend to a range of structural cardiac maladies, including disorders of the tricuspid, aortic, and mitral valves, as well as heart failure. Founded in 2011, the company maintains its principal place of business in Ningbo, People's Republic of China.
Prezzo delle azioni
$0.90187992
Capitalizzazione di mercato
$376.23M
Variazione (1 giorno)
-2.69%
Variazione (1 anno)
-14.56%
Paese
CN
Scambia Jenscare Scientific Co., Ltd. (9877)

Categoria

Storico del rendimento da dividendi per Jenscare Scientific Co., Ltd. (9877)
Il rendimento da dividendi (TTM) di Jenscare Scientific Co., Ltd. (simbolo azionario: 9877) al 2026 è: 0
Rendimento medio negli ultimi 5 anni: 0.00%
Storico del rendimento da dividendi per Jenscare Scientific Co., Ltd. (9877) da 2026 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
Anno Rendimento da dividendi Cambia
Non abbastanza dati per le date fornite.
Rendimenti da dividendi (TTM) di aziende simili o concorrenti